Home » Topics » BioWorld Science

BioWorld Science
RSS

CureVac and myNEO enter research and option agreement toward development of mRNA cancer vaccines

May 26, 2022

U.S. researchers present new NR1D2 agonists

May 26, 2022

New EGFR inhibitors identified at Lengo Therapeutics

May 26, 2022

Rhizen Pharmaceuticals divulges new PARP inhibitors

May 26, 2022

Evusheld retains neutralization activity against SARS-CoV-2 Omicron BA.4 and BA.5 variants

May 26, 2022

Bivalent Epstein-Barr nanoparticle vaccine protects against infection in mice

May 26, 2022

Newave Pharmaceutical discloses new BTK inhibitors

May 26, 2022

Integral BioSciences patents ENPP1 inhibitors

May 26, 2022

ATV-006, orally bioavailable antiviral candidate against SARS-CoV-2

May 26, 2022

CNPY4 knockout embryos exhibit hedgehog signaling hyperactivation-driven defects

May 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...